Raanani P - Search Results

1

Total therapy-based treatment for multiple myeloma--a single center experience.

Magen-Nativ H, Ram R, Yeshurun M, Gafter-Gvili A, Raanani P, Shpilberg O. Magen-Nativ H, et al. Among authors: raanani p. Ann Hematol. 2010 Jan;89(1):53-9. doi: 10.1007/s00277-009-0767-x. Epub 2009 Jun 6. Ann Hematol. 2010. PMID: 19504094

2

[2-chlorodeoxyadenosine (2-CdA) cladribine therapy in hairy cell leukemia].

Raanani P, Shpilberg O, Ben-Bassat I. Raanani P, et al. Harefuah. 1994 Jun 1;126(11):673-6. Harefuah. 1994. PMID: 7927005 Review. Hebrew. No abstract available.

3

Acute leukemia relapse presenting as central diabetes insipidus.

Ra'anani P, Shpilberg O, Berezin M, Ben-Bassat I. Ra'anani P, et al. Cancer. 1994 May 1;73(9):2312-6. doi: 10.1002/1097-0142(19940501)73:9<2312::aid-cncr2820730912>3.0.co;2-i. Cancer. 1994. PMID: 8168035 Review.

4

Postremission therapy with two different dose regimens of cytarabine in adults with acute myelogenous leukemia.

Shpilberg O, Haddad N, Sofer O, Raanani P, Berkowicz M, Chetrit A, Carter A, Ramot B, Tatarski I, Ben-Bassat I. Shpilberg O, et al. Among authors: raanani p. Leuk Res. 1995 Dec;19(12):893-7. doi: 10.1016/0145-2126(95)00082-8. Leuk Res. 1995. PMID: 8632657

5

The MACOP-B and VACOP-B combination chemotherapy for young patients with intermediate-grade non-Hodgkin's lymphoma.

Dreiher J, Shpilberg O, Raanani P, Chetrit A, Ben-Bassat I. Dreiher J, et al. Among authors: raanani p. Leuk Res. 1998 Nov;22(11):997-1002. doi: 10.1016/s0145-2126(98)00106-4. Leuk Res. 1998. PMID: 9783801 Clinical Trial.

6

Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine.

Raanani P, Shpilberg O, Gillis S, Avigdor A, Hardan I, Berkowicz M, Sofer O, Lossos I, Chetrit A, Ben-Yehuda D, Ben-Bassat I. Raanani P, et al. Leuk Res. 1999 Aug;23(8):695-700. doi: 10.1016/s0145-2126(99)00078-8. Leuk Res. 1999. PMID: 10456666

7

[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].

Avigdor A, Hardan I, Shpilberg O, Raanani P, Grotto I, Ben-Bassat I. Avigdor A, et al. Among authors: raanani p. Harefuah. 2000 Sep;139(5-6):174-9, 248, 247. Harefuah. 2000. PMID: 11062945 Hebrew.

8

[Treatment of adults with acute lymphoblastic leukemia--results at the Sheba Medical Center, Tel-Hashomer, 1977-1988].

Goldstein G, Shpilberg O, Raanani P, Chetrit A, Ben-Bassat I. Goldstein G, et al. Among authors: raanani p. Harefuah. 2000 Oct;139(7-8):255-9, 328, 327. Harefuah. 2000. PMID: 11062964 Hebrew.

9

Engraftment-associated hypophosphatemia--the role of cytokine release and steep leukocyte rise post stem cell transplantation.

Raanani P, Levi I, Holzman F, Grotto I, Brok-Simoni F, Avigdor A, Davidson J, Shpilberg O, Ben-Bassat I. Raanani P, et al. Bone Marrow Transplant. 2001 Feb;27(3):311-7. doi: 10.1038/sj.bmt.1702761. Bone Marrow Transplant. 2001. PMID: 11277180

10

Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma.

Shimoni A, Hardan I, Avigdor A, Yeshurun M, Raanani P, Ben-Bassat I, Nagler A. Shimoni A, et al. Among authors: raanani p. Br J Haematol. 2003 Aug;122(3):457-64. doi: 10.1046/j.1365-2141.2003.04446.x. Br J Haematol. 2003. PMID: 12877674 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters